1.Introduction to Enteric-Coated HPMC Hollow Capsules:
Enteric-coated HPMC hollow capsules are pharmaceutical capsules with a specialized coating that enables them to withstand the acidic environment of the stomach and dissolve in the alkaline environment of the small intestine. This unique feature distinguishes them from conventional capsules, making them suitable for medications sensitive to gastric acid or those requiring targeted release in the intestines.

2.Protective Mechanism:
The primary function of enteric coating in HPMC hollow capsules is to protect medications from the harsh acidic environment of the stomach. The enteric coating, typically composed of polymers like methacrylic acid copolymers, forms a pH-dependent barrier that remains intact in the acidic pH of the stomach but dissolves in the alkaline pH of the small intestine. This delayed dissolution ensures that the medication remains encapsulated during gastric transit, preventing premature release and degradation.

3.Prevention of Gastric Irritation:
Medications with enteric-coated HPMC hollow capsules are less likely to cause gastric irritation or ulceration. By bypassing the stomach and releasing the medication in the intestines, these capsules reduce the direct contact of APIs with the gastric mucosa, thereby minimizing adverse gastrointestinal effects.

4.Enhanced Medication Stability:
Enteric-coated HPMC hollow capsules contribute to the stability of medications, especially those susceptible to degradation in acidic environments. By shielding the APIs from gastric acid, the capsules help maintain their chemical integrity and potency throughout their journey in the gastrointestinal tract, ultimately ensuring consistent therapeutic outcomes.

5.Optimized Drug Absorption:
The targeted release of medications in the small intestine, facilitated by enteric-coated HPMC hollow capsules, enhances drug absorption. The alkaline pH environment of the intestines promotes the dissolution of the enteric coating, allowing the liberated drug to be efficiently absorbed through the intestinal mucosa into the bloodstream.

6.Reduced Gastrointestinal Side Effects:
Enteric-coated HPMC hollow capsules can mitigate gastrointestinal side effects associated with certain medications. By delivering the drug to the intestines rather than the stomach, these capsules minimize irritation of the gastric mucosa, decreasing the likelihood of symptoms such as nausea, vomiting, or gastritis.

7.Customization and Formulation Flexibility:
Pharmaceutical manufacturers have the flexibility to customize enteric-coated HPMC hollow capsules to suit specific medication formulations and patient needs. The hollow structure of the capsules allows for precise dosing and accommodates a wide range of drug formulations, including granules, pellets, or multiparticulate systems.

8.Applications in Pharmaceutical Industry:
Enteric-coated HPMC hollow capsules find extensive applications in the pharmaceutical industry, particularly in the development of oral dosage forms for acid-labile drugs, delayed-release formulations, and medications requiring enteric protection. Their versatility and efficacy make them a preferred choice for drug delivery systems aimed at optimizing therapeutic outcomes.

Enteric-coated HPMC Hollow Capsules

Product introduction: It can achieve the purpose of targeted drug delivery, and is a targeted capsule product with high compatibility.
Product Category: Pharmaceutical Excipients
Product advantages: Enteric-coated hypromellose hollow capsules have the excellent characteristics of vegetable capsules and enteric-coated capsules: low water content, high stability.